COMBINATION OF AN ALDOSTERONE RECEPTOR ANTAGONIST AND AN HMG COA REDUCTASE INHIBITOR

Details for Australian Patent Application No. 2002322526 (hide)

Owner PHARMACIA CORPORATION

Inventors ROCHA, Ricardo; KELLER, Bradley, T.; MCMAHON, Ellen, G.

Pub. Number AU-A-2002322526

PCT Number PCT/US02/22896

PCT Pub. Number WO2003/007993

Priority 60,306,336 19.07.01 US

Filing date 18 July 2002

Wipo publication date 3 March 2003

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/585

A61K 031/44 - Non-condensed pyridines

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/365 - Lactones

A61K 031/22

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60,306,336 19.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322526

20 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322527-Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

2002322525-System and method of measuring flow velocity in three axes